Erich Mohr serves as Executive at DelMar Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Erich Mohr has executed 9 insider transactions totaling $15.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 30, 2018 involved transacting 528 shares valued at $1.7K.
Erich Mohr currently holds 8,222 shares of DelMar Pharmaceuticals, Inc. (DMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erich Mohr has been a net buyer of DMPI stock. They have purchased $15.0K and sold $0 worth of shares.
Erich Mohr's most recent insider trade was on Mar 30, 2018, when they sold 528 shares at $3.20 per share.
Get notified when new Form 4 filings are submitted
| $3.20 |
| Discretionary |
| Sep 29, 2017 | DMPI | $1.7K | Other | 528 | $3.20 | Discretionary |
| Jun 30, 2017 | DMPI | $1.7K | Other | 528 | $3.20 | Discretionary |
| Jun 26, 2017 | DMPI | $15.0K | Purchase | 4,167 | $3.60 | Discretionary |
| Mar 31, 2017 | DMPI | $1.7K | Other | 528 | $3.20 | Discretionary |
| Dec 31, 2016 | DMPI | $1.7K | Other | 528 | $3.20 | Discretionary |
| Oct 3, 2016 | DMPI | $1.7K | Other | 528 | $3.20 | Discretionary |
| Jul 18, 2016 | DMPI | $1.1K | Other | 359 | $3.20 | Discretionary |